{"meshTagsMajor":["Polymorphism, Genetic","Tumor Suppressor Proteins"],"meshTags":["Age Distribution","Aged","Biomarkers, Tumor","Case-Control Studies","Cohort Studies","Humans","Male","Middle Aged","Mutation","Odds Ratio","PTEN Phosphohydrolase","Phosphoric Monoester Hydrolases","Polymorphism, Genetic","Prevalence","Prognosis","Prostatic Neoplasms","Reference Values","Risk Assessment","Sensitivity and Specificity","Tumor Suppressor Proteins"],"meshMinor":["Age Distribution","Aged","Biomarkers, Tumor","Case-Control Studies","Cohort Studies","Humans","Male","Middle Aged","Mutation","Odds Ratio","PTEN Phosphohydrolase","Phosphoric Monoester Hydrolases","Prevalence","Prognosis","Prostatic Neoplasms","Reference Values","Risk Assessment","Sensitivity and Specificity"],"genes":["PTEN"],"publicationTypes":["Comparative Study","Journal Article"],"title":"An intronic variant in PTEN is not associated with prostate cancer risk.","pubmedId":"11303600"}